Zavegepant Nasal Spray for the Acute Treatment of Migraine With Aura and Without Aura: Pooled Results From 2 Randomized, Placebo-Controlled Clinical Trials

被引:0
|
作者
Smith, T. [1 ]
Pavlovic, J. [2 ]
Mullin, K. [3 ]
Joshi, S. [4 ]
Croop, R. [5 ]
Mosher, L. [5 ]
Lovegren, M. [6 ]
Forshaw, M. [6 ]
Lipton, R. [2 ]
机构
[1] Study Metrix Res, St Petersburg, FL USA
[2] Albert Einstein Coll Med, Bronx, NY USA
[3] New England Inst Neurol & Headache, Stamford, CT USA
[4] Community Neurosci Serv, Westborough, MA USA
[5] Pfizer Inc, New York, NY USA
[6] Biohaven Pharmaceut, New Haven, CT USA
来源
HEADACHE | 2023年 / 63卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-212
引用
收藏
页码:182 / 183
页数:2
相关论文
共 50 条
  • [41] Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials
    Charleston, Larry
    Armand, Cynthia
    Helveston, Wendell
    Monteith, Teshamae
    O'Brien, Hope
    Croop, Robert
    Thiry, Alexandra
    Morris, Beth
    Forshaw, Micaela
    Abbott, Chandra
    NEUROLOGY, 2023, 100 (17)
  • [42] Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine in Black and African American Adults: Results From 3 Randomized, Placebo-Controlled Clinical Trials
    Charleston, L.
    Armand, C.
    Helveston, W.
    Monteith, T.
    O'Brien, H.
    Croop, R.
    Thiry, A.
    Morris, B.
    Forshaw, M.
    Abbott, C.
    HEADACHE, 2023, 63 : 131 - 132
  • [43] A phase 2 multicenter, randomized, double-blind, parallel-group, placebo-controlled study of NXN-188 dihydrochloride in acute migraine without aura
    Medve, R. A.
    Lategan, T. W.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S38 - S38
  • [44] Efficacy of the anticonvulsant topiramate in the prophylactic treatment of episodic migraine: A pooled analysis from two randomized, placebo-controlled trials
    Edwards, KR
    Hulihan, J
    Kraut, L
    Kamin, M
    ANNALS OF NEUROLOGY, 2000, 48 (03) : 486 - 486
  • [45] A Double-Blind, Placebo-Controlled, Study Evaluating the Efficacy of DFN-02 (Nasal Spray of Sumatriptan 10mg+Permeation Enhancer) in Migraine With or Without Aura
    Munjal, Sagar
    Brand-Schieber, Elimor
    CEPHALALGIA, 2017, 37 : 363 - 364
  • [46] OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phase of the PREEMPT Clinical Program
    Dodick, David W.
    Aurora, Sheena K.
    Turkel, Catherine C.
    DeGryse, Ronald E.
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diener, Hans-Christopher
    Brin, Mitchell F.
    NEUROLOGY, 2010, 74 (09) : A281 - A281
  • [47] OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phase of the PREEMPT clinical program
    Dodick, D. W.
    Aurora, S. K.
    Turkel, C. C.
    DeGryse, R. E.
    Silberstein, S. D.
    Lipton, R. B.
    Diener, H. C.
    Brin, M. F.
    TOXICON, 2013, 68 : 110 - 110
  • [48] OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
    Dodick, David W.
    Turkel, Catherine C.
    DeGryse, Ronald E.
    Aurora, Sheena K.
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diener, Hans-Christoph
    Brin, Mitchell F.
    HEADACHE, 2010, 50 (06): : 921 - 936
  • [49] Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura A Secondary Analysis of Randomized Clinical Trials
    Ashina, Messoud
    Goadsby, Peter J.
    Dodick, David W.
    Tepper, Stewart J.
    Xue, Fei
    Zhang, Feng
    Brennan, Francis
    Lima, Gabriel Paiva da Silva
    JAMA NEUROLOGY, 2022, 79 (02) : 159 - 168
  • [50] Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine
    Silberstein, S
    Tepper, S
    Brandes, J
    Diamond, M
    Goldstein, J
    Winner, P
    Venkatraman, S
    Vrijens, F
    Malbecq, W
    Lines, C
    Visser, WH
    Reines, S
    Yuen, E
    NEUROLOGY, 2004, 62 (09) : 1552 - 1557